TABLE 1.

Reported positive effects of empagliflozin treatment on different aspects of daily life of GSD Ib patients and caregivers.

Improvement
Overall quality of life	82% of patients (60/73)
Appetite	63% of patients (35/56)
Physical performance and activity	75% of patients (42/56)
Overall well‐being of the patient	96% of patients (66/69)
Overall well‐being of the caregiver	94% of caregivers (50/53)
Sleep of the patient	63% of patients (33/52)
Sleep of the caregiver	67% of caregivers (28/42)
Traveling	89% of patients (65/73)
Reduction
Number of hospitalizations	66% of patients (48/73)
Sick‐day leaves of patients	67% of patients (49/73)
Sick‐day leaves of caregivers of pediatric patients	27% of caregivers (12/44)